Meta-analysis on aspirin combined with low-molecular-weight heparin for improving the live birth rate in patients with antiphospholipid syndrome and its correlation with d-dimer levels

Management of antiphospholipid syndrome

(2020) Anisur Rahman   CLINICAL RHEUMATOLOGY

Combined hereditary thrombophilias are responsible for poor placental vascularization development and low molecular weight heparins (LMWH) prevent adverse pregnancy outcomes in these patients

(2020) Miroslava G. Gojnic et al.   Journal of Maternal-Fetal & Neonatal Medicine

Comparison of 2 approaches in management of pregnant women with inherited trombophilias

(2019) Stefan Dugalic et al.   MEDICINE

Prothrombotic state of patients with unexplained recurrent spontaneous abortion

(2015) Xuefeng Lu et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

14th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome

(2014) Guilherme R. de Jesus et al.   AUTOIMMUNITY REVIEWS

Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: An international and collaborative meta-analysis

(2013) Laurent Arnaud et al.   AUTOIMMUNITY REVIEWS

Antiphospholipid syndrome and pregnancy

(2012) Klára Gadó et al.   ORVOSI HETILAP

Heparin Treatment in Antiphospholipid Syndrome With Recurrent Pregnancy Loss

(2010) Panayiotis D. Ziakas et al.   OBSTETRICS AND GYNECOLOGY

Low Molecular Weight Heparin and Aspirin for Recurrent Pregnancy Loss: Results from the Randomized, Controlled HepASA Trial

(2009) C. A. LASKIN et al.   JOURNAL OF RHEUMATOLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE